drugset / Trial / NCT06449027
Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is to assess the safety, efficacy and pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.
Timeline
- Start
- 2024-08-21
- Primary completion
- 2025-11
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leuprolide | Other / unclassified | 11.25 mg | — |
| Subject | Leuprolide | Other / unclassified | 42 mg | — |
| Background | Tamoxifen | Small molecule | 10 mg | — |